A Pilot Study of Terazosin for Parkinson's Disease

Clinical trial NCT03905811 · COMPLETED

Trial details

NCT number: NCT03905811
Sponsor: Jordan Schultz
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2019-09-24
Primary completion: 2020-06-05
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.